{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:53:38Z","timestamp":1761292418351},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":2270,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.bbadis.2007.02.003","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T20:51:07Z","timestamp":1172609467000},"page":"587-596","source":"Crossref","is-referenced-by-count":40,"title":["Enzyme enhancement activity of N-octyl-\u03b2-valienamine on \u03b2-glucosidase mutants associated with Gaucher disease"],"prefix":"10.1016","volume":"1772","author":[{"given":"Ke","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruaki","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michitaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikatsu","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousaku","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2007.02.003_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2641","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bbadis.2007.02.003_bib2","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2007.02.003_bib3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2007.02.003_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(98)90023-6","article-title":"Enzyme therapy for Gaucher disease: the first 5 years","volume":"12","author":"Grabowski","year":"1998","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbadis.2007.02.003_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/08035250500423804","article-title":"Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease","volume":"95","author":"Erikson","year":"2006","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bbadis.2007.02.003_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1010335505357","article-title":"Inhibition of substrate synthesis as a strategy for glycolipids lysosomal storage disease therapy","volume":"24","author":"Platt","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2007.02.003_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2007.02.003_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<16::AID-AJMG3>3.0.CO;2-O","article-title":"Gaucher disease: enzyme therapy in the acute neuronopathic variant","volume":"71","author":"Prows","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2007.02.003_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004310000630","article-title":"Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb","volume":"160","author":"Aoki","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2007.02.003_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","article-title":"Substrate reduction therapy of glycosphingolipid storage disorders","volume":"29","author":"Aerts","year":"2006","journal-title":"Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2007.02.003_bib11","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2007.02.003_bib12","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.biocel.2005.05.008","article-title":"Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease","volume":"37","author":"Schmitz","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2007.02.003_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","article-title":"Therapeutic strategies to ameliorate lysosomal storage disorders\u2014A focus on Gaucher disease","volume":"63","author":"Sawkar","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2007.02.003_bib14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nrg963","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"3","author":"Desnick","year":"2002","journal-title":"Nat. Rev., Genet."},{"key":"10.1016\/j.bbadis.2007.02.003_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-Octyl-\u03b2-valienamine up-regulates activity of F213I mutant \u03b2-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2007.02.003_bib16","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S \u03b2-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2007.02.003_bib17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbadis.2007.02.003_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tem.2004.05.003","article-title":"Pharmacological chaperones: potential treatment for conformational diseases","volume":"15","author":"Bernier","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2007.02.003_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1022553819241","article-title":"Clinical and molecular characteristics of Japanese Gaucher disease","volume":"24","author":"Eto","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2007.02.003_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0009-9120(87)90010-5","article-title":"Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid \u03b2-glucosidase activities","volume":"20","author":"Vaccaro","year":"1987","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbadis.2007.02.003_bib21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02265","article-title":"Therapeutic approaches to protein-misfolding diseases","volume":"426","author":"Cohen","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2007.02.003_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomeal \u03b1-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2007.02.003_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0960-894X(96)00146-1","article-title":"Synthesis of potent \u03b2-d-glucocerebrosidase inhibitors: N-alkyl-\u03b2-valienamines","volume":"6","author":"Ogawa","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbadis.2007.02.003_bib24","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0968-0896(98)00143-6","article-title":"Chemical modification of \u03b2-glucocerebrosidase inhibitor N-octyl-\u03b2-valienamine: synthesis and biological evaluation of N-alkanoyl and N-alkyl derivatives","volume":"6","author":"Ogawa","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbadis.2007.02.003_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid \u03b2-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2007.02.003_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.embor.embor873","article-title":"X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease","volume":"4","author":"Dvir","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbadis.2007.02.003_bib27","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443907000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443907000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T02:21:45Z","timestamp":1547000505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443907000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0925443907000385"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2007.02.003","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}